Navigation Links
National Psoriasis Foundation Launches "Seal of Recognition" for Psoriasis Products
Date:2/28/2012

PORTLAND, Ore., Feb. 28, 2012 /PRNewswire-USNewswire/ -- For the first time, consumers shopping for over-the-counter products to treat psoriasis—a disease of the immune system that appears on the skin, affecting as many as 7.5 million Americans—and psoriatic arthritis—an inflammatory joint and tendon disease—will find a National Psoriasis Foundation Seal of Recognition on items that dermatology experts deem effective in relieving disease symptoms. Learn about the program at www.psoriasis.org/licensing.

(Photo: http://photos.prnewswire.com/prnh/20120228/DC61286-a)

(Photo: http://photos.prnewswire.com/prnh/20120228/DC61286-b)

Five products for scalp psoriasis made by Neutrogena Corp. and one product by Alva-Amco Pharmacal are the first to feature the seal. Available on store shelves nationwide, the seal products include the Neutrogena line of T/Gel Therapeutic Shampoo in three formulations: "Original Formula," "Extra Strength" and "Stubborn Itch"; T/Gel Therapeutic Conditioner; and T/Sal Therapeutic Shampoo.

People with plaque psoriasis—the most prevalent form of the disease, affecting up to 80 percent of people with psoriasis—will find the Foundation seal on Alva-Amco's Psoriasin Gel in all major pharmacies.

"Improving the quality of life for people with psoriasis and psoriatic arthritis is the reason the Foundation has launched its seal program," said Eric Kimble, National Psoriasis Foundation Board of Trustees member and head of the corporate review committee for the seal. "The seal will help consumers identify, from a maze of available products, items that could provide a benefit for psoriatic diseases."

To qualify for Foundation recognition, products are reviewed by a panel of dermatology experts who make sure the items meet the following criteria, including:

  • Products that hydrate the skin, reduce redness, reduce joint pain and/or provide aid for people with psoriatic arthritis;
  • Nonprescription products;
  • Non-irritating products;
  • Products that can be used along with prescription remedies.

The panel also reviews the products' ingredients and safety, toxicity and formulation data.

"Neutrogena is honored to continue to partner with the National Psoriasis Foundation and feature the Foundation's 'Seal of Recognition' on our T/Gel products," said Lindsay Wade, Neutrogena brand manager. "We are committed to helping those with psoriasis and hope the seal helps drive psoriasis awareness and reinforce Neutrogena's dedication to improve lives."

"For patients new to non-prescription psoriasis care options, the NPF Seal affirms that the Psoriasin Gel formula is recognized as one that can be expected to offer psoriasis symptom relief.  Furthermore, the seal will prompt people with psoriasis to seek out the Foundation to learn more about psoriasis care," notes Mike Reisner, vice-president of marketing at Alva-Amco Pharmacal Companies, Inc.

The National Psoriasis Foundation Seal of Recognition is a consumer education program intended to improve the quality of life for millions of Americans living with psoriasis and psoriatic arthritis. The seal program is available for the following product categories: personal care products, household products, fabrics and devices.

To learn more about the Seal of Recognition, visit www.psoriasis.org/licensing.

About Psoriasis
Psoriasis is the most prevalent autoimmune disease in the country, affecting as many as 7.5 million Americans. Appearing on the skin most often as red scaly patches that itch and bleed, psoriasis is chronic, painful, disfiguring and disabling. Up to 30 percent of people with psoriasis develop psoriatic arthritis, a related joint disease. There is no cure for psoriasis.  

About the National Psoriasis Foundation
National Psoriasis Foundation is the world's largest nonprofit organization serving people with psoriasis and psoriatic arthritis. Our mission is to find a cure for psoriasis and psoriatic arthritis and to eliminate their devastating effects through research, advocacy and education. For more information, call the Psoriasis Foundation, headquartered in Portland, Ore., at 800.723.9166, or visit www.psoriasis.org. Follow the Psoriasis Foundation on Facebook and Twitter.


'/>"/>
SOURCE National Psoriasis Foundation
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Leading Industry Multinationals Participate in Medical Device Costa Rica Panel: "Developing a Strong Supplier Base"
2. DIA and National Pharmaceutical Council Will Host Two-Day Conference on Comparative Effectiveness Research
3. PAREXEL International to Present at Cowen Healthcare Conference and Raymond James Investors Conference
4. Osseon® Announces International Distribution Agreement with Aesculap
5. NMEDA Introduces National Mobility Awareness Month for Seniors, Veterans and People with Disabilities
6. CVS Caremarks MinuteClinic to Deploy Allscripts EHR Nationally
7. SurgLine International, Inc. Update to Shareholders on Revenue Pipeline and Organizational Changes
8. National Coalition Holds Prescription Drug Take-back Day in Palm Springs Ahead of Pain Medicine Scientific Meeting
9. Access Pharmaceuticals MuGard Added to Nationally Ranked Childrens Hospital of Colorado Pharmacy Formulary
10. To Take a Glance Cutting Edge Medicine Equipment! The 28th International Medical & Hospital Equipment Show
11. National Data Center Hosting Provider, CoreLink Data Centers, to Present at HIMSS 2012
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/9/2016)... Research and Markets has announced the addition of ... offering. ... report forecasts the global optical transceiver market to grow at a ... report covers the present scenario and the growth prospects of the ... the report considers the revenue generated from the shipment of optical ...
(Date:12/9/2016)...  Harmar Mobility, LLC announced today that Steven E. Dawson has been ... of Directors. Photo - http://photos.prnewswire.com/prnh/20161209/447552 ... Harmar ... Mr. Dawson,s executive career includes leadership roles managing ... of industries. He brings to the company deep operational and leadership expertise, ...
(Date:12/9/2016)... aTyr Pharma, Inc. (Nasdaq: LIFE ), a ... to address severe, rare diseases, today announced that senior management will ... Success Healthcare Conference at the InterContinental Barclay Hotel in ... 4:20 p.m. ET. About aTyr Pharma ... aTyr Pharma is engaged ...
Breaking Medicine Technology:
(Date:12/9/2016)... (PRWEB) , ... December 09, 2016 , ... The ... Drug Dependence, Inc. (NCADD) is recommending the film Whispering Spirits and ... the District of Columbia as an education tool in the war against teen drug ...
(Date:12/9/2016)... ... December 09, 2016 , ... Mediaplanet today announces distribution of the latest ... readers to sign up as an organ donor for the 123,000 people in the ... organ donor can save up to 8 saves through organ donation and enhance many ...
(Date:12/9/2016)... (PRWEB) , ... December 09, 2016 , ... "I had ... an inventor from Winchester, Va. "I thought that if the nebulizer had a more ... rather than fearing them." , He developed the patent-pending NEBY to avoid the need ...
(Date:12/8/2016)... ... 08, 2016 , ... The Florida Hospital Tampa Wound Healing ... Society (UHMS), the leading authority in hyperbaric medicine. This accreditation identifies the Institute ... and facilities have earned this distinction. This is the second time the Florida ...
(Date:12/8/2016)... ... 2016 , ... ZyDoc , a New York-based medical ... Capture Methods for Input to Electronic Health Records: A Comparative Usability Study” has ... usability study demonstrate that a dictation-based method (“NLP Entry”) using ZyDoc’s MediSapien™ natural ...
Breaking Medicine News(10 mins):